References
- Shriver A D, Rosenthale M E, Kluender H C, Schut R N, McGuire J L, Hong E. Pharmacology of riop-rostil, a new gastric cytoprotective/antisecretory agent. Arzneim Forsch/Drug Res 1985; 35: 839–843
- Demol P, Wingender W, Weihrauch T R, Graefe K H. Inhibition of gastric secretion in man by riop-rostil, a new synthetic methyl prostaglandin E. Arzneim Forsch/Drug Res 1985; 35: 861–863
- Katz L B, Shriver D A, Capetola R J, Genna T, Argentieri D C, Rosenthale M E. Rioprostil prevents gastric lesions induced by nonsteroidal antiinflammatory drugs (NSAIDs) in adjuvant arthritic (AA) rats. Fed Proc 1985; 44: 733
- Quadros E, Ramsamooj E, Rajapaksa T, Wilson D E. Cytoprotective effects of a prostaglandin E1 (PGE1) analogue: Relationship to mucus synthesis and release in man and the rat. Gastroenterology 1984; 86: 1214
- De Boer Th J, Backer H J. Diazomethane. Org Synth 1956; 36: 16–19
- Vane F, Horning M G. Separation and characterization of the prostaglandins by gas chromatography and mass spectrometry. Anal Lett 1969; 2: 357–371
- Grob K, Grab G. Techniques of capillary gas chromatography. Possibilities of the full utilization of high-performance columns. Part I: Direct sample injection. Chromatographia 1972; 5: 3–12
- Sies H. The use of perfusion and liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systems. Methods in Enzymology, S Fleischer, L Packer. Academic Press, New York 1978; Vol 52: 48–49
- Green K. Metabolism of prostaglandin E2 in the rat. Biochemistry 1971; 10: 1072–1086
- Hamberg M, Samuelsson B. On the metabolism of prostaglandins E1 and E2 in man. J Biol Chem 1971; 246: 6713–6721
- Ånggård E, Larsson C. The sequence of the early steps in the metabolism of prostaglandin E. Eur J Pharmacol 1971; 14: 66–70